Indapen SR

Quick links to important sections

Indapen SR

Treatment option: Hypertension

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Indapen SR

Property Description
Active Ingredient Indapamide (Sulfonamide Derivative)
Form Oral Sustained Release (SR) Tablet
Pharmacological Class Thiazide-like Diuretic, Antihypertensive Agent
Primary Action Natriuresis (salt excretion), Direct Vascular Effect
Origin Synthetic Compound

The Core Identity: What is Indapen SR and Its Active Ingredient?

Indapen SR is a synthetic pharmaceutical preparation provided as an oral tablet containing the active ingredient Indapamide. This medication is classified as a thiazide-like diuretic and is clinically recognized as an antihypertensive agent. Indapamide belongs to the chemical group of sulfonamide derivatives, and its distinct molecular structure provides specific pharmacological properties. Its primary role is to serve as a foundational component in the management of elevated systemic pressure.

Form and Delivery: Why is Indapen SR a Sustained Release Tablet?

The "SR" in Indapen SR denotes a specialized Sustained Release or modified release formulation of the tablet. This delivery system is engineered to provide a predictable and controlled dispersion of Indapamide into the body. This mechanism ensures that the active substance is released slowly and consistently over a prolonged duration, minimizing concentration variations that may occur with immediate-release forms. This controlled release is a feature associated with stable therapeutic effects across the entire dosing period, supporting long-term, once-daily systemic management.

Primary Function: What is the General Purpose of Indapamide?

The overall purpose of Indapamide is to assist in the regulation of systemic pressure and normalize fluid volume. It functions through a potent diuretic action, which involves inhibiting the renal reabsorption of sodium and chloride ions, resulting in increased excretion of salt and water. Further enhancing its action, Indapamide also exerts a direct vascular effect, which contributes to the relaxation and widening of the blood vessel walls. This combination of fluid reduction and decreased peripheral vascular resistance is essential to its general role in circulatory pressure regulation.

Regulatory References

  1. Indapamide - MeSH (NIH)

What side effects are possible with Indapen SR?

Possible Side Effects and Safety Information: Indapen SR

The safety profile of Indapen SR (Indapamide Sustained Release) is characterized by officially documented adverse reactions, classified by frequency and system-organ effects, as defined in regulatory texts. The most frequent reactions relate to its action as a thiazide-like diuretic.

Official Adverse Reaction Frequencies

Side effects are categorized based on their documented occurrence rate in clinical use, according to regulatory standards:

  • Common (may affect up to 1 in 10 people): Low blood potassium (Hypokalaemia) and hypersensitivity reactions, primarily presenting as a red raised skin rash.
  • Uncommon (may affect up to 1 in 100 people): Low blood sodium (Hyponatraemia), vomiting, purpura, and erectile dysfunction.
  • Rare: Symptoms such as headache, fatigue, dizziness, nausea, and dry mouth.

System-Organ Class and Serious Reactions

Adverse events are formally grouped by the system they affect, including Metabolism and Nutrition Disorders (e.g., electrolyte imbalance), Skin and Subcutaneous Tissue Disorders, and Eye Disorders. While rare, regulatory documents highlight potentially serious reactions classified as Very Rare or of Not Known frequency, such as severe, life-threatening skin reactions (Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), Acute Angle-Closure Glaucoma, and the irregular heartbeat known as Torsade de pointes.

Population-Specific Safety Notes

The official labeling notes specific considerations for certain groups. Caution is documented for use in older adults, where there is a reported increased risk of severe low sodium and potassium levels. Furthermore, the medicine is contraindicated in patients with severe hepatic impairment or severe renal impairment (creatinine clearance below 30 ml/min), and in those with pre-existing hypokalaemia. Symptoms such as dizziness and fatigue are officially noted as more likely to occur at the initiation of treatment and following dose increases.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Indapen SR (Indapamide) is defined by its effects on fluid and electrolyte balance, which can lead to systemic instability and severe cardiovascular effects.

Documented Overdose Manifestations

Category Clinical Presentation
Systemic Effects Hypotension (low blood pressure), Nausea, Vomiting, Dizziness, Somnolence, and profound weakness.
Physiological Findings Severe fluid and electrolyte disturbances, specifically documented as Hypokalemia and Hyponatremia, potentially leading to changes in urine output.
Severe Outcomes Marked hypotension, Respiratory Depression, and, in very severe cases, progression to Coma or seizure.

Emergency Action Required

Regulatory information mandates that immediate medical attention must be sought upon suspicion of an overdose. Emergency services must be contacted immediately if the affected person has collapsed, experienced a seizure, or cannot be awakened.

Since no specific antidote is known for Indapamide overdose, management is strictly symptomatic and supportive. This approach includes gastric decontamination and the critical restoration of fluid and electrolyte balance under intensive hospital monitoring. Monitoring must focus on serum electrolytes and vital signs. Population-specific notes indicate that elderly females may face an increased risk of severe hyponatremia, and individuals with hepatic impairment face the risk of hepatic coma.

Therapeutic Uses of Indapen SR

What Indapen SR Treats: Main Uses and Benefits

Indapen SR (Indapamide Sustained Release) is generally used as a foundational therapy for addressing two major, interconnected therapeutic domains, commonly assisting with managing chronic conditions. This medication is considered relevant for managing conditions related to systemic balance.


Symptom Management and Therapeutic Domains

The primary role of Indapen SR is commonly used to help with persistently elevated systemic pressure (essential hypertension). It is generally applied in conditions where blood pressure requires long-term stabilization, either as an initial agent or in combination with other therapies. The therapeutic benefits contribute to improved comfort during periods of heightened symptoms and assists with maintaining functional stability by easing the noticeable physiological strain caused by chronic hypertension.

Additionally, the medication may be part of symptomatic management for the symptom cluster of fluid retention (edema), particularly when this swelling is associated with certain chronic heart conditions. It helps with maintaining functional stability by assisting with the reduction of physical swelling and the overall fluid burden. The treatment provides support that helps ease the overall symptom burden and helps maintain a sense of stability when symptoms are more noticeable. The medication is relevant for easing the impact of symptoms linked to organ-specific functional stress by contributing to the protective management of organs from the effects of high pressure.


Quick Fact: Management for Systemic Pressure and Fluid

Indapen SR is relevant for managing two core conditions: essential hypertension and fluid retention associated with chronic heart conditions. Its primary benefit is providing consistent support to maintain stable pressure and assist with managing fluid buildup.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Indapen SR

Official regulatory documents define strict criteria for the use of Indapen SR (Indapamide Sustained Release), specifying who is eligible and who is absolutely prohibited from taking the medicine.


Contraindicated Populations (Must Not Use)

The medicine must not be used if a patient meets any of the following absolute non-eligibility criteria, as stated in official labeling:

  • Hypersensitivity: Known allergy to the active ingredient, Indapamide, or any related sulfonamide-type medications.
  • Severe Organ Dysfunction: The presence of severe renal failure (creatinine clearance less than 30 mL/ min) or hepatic encephalopathy/severe liver impairment.
  • Electrolyte Disorder: The presence of refractory hypokalaemia (low potassium levels that do not respond to treatment).
  • Excipient Intolerance: Diagnosed with hereditary galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.

Age and Life Stage Restrictions

Population Group Regulatory Status
Adults (18+ years) Eligible for use if no contraindications exist.
Older Adults Eligible, but use requires caution and monitoring of renal function.
Pediatric (Under 18) Use is not recommended; safety and efficacy are not established due to a lack of data.
Pregnancy/Lactation Use is contraindicated (pregnancy) or not recommended (lactation).

Note on Eligibility: Eligibility is based strictly on these regulatory constraints; individuals with non-severe hepatic or renal impairment may be eligible but require special medical caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific restrictions and requirements for the co-administration of Indapamide SR with other substances.

Contraindications and High-Risk Combinations

The combination of Indapamide SR with Aliskiren is formally contraindicated in patients diagnosed with diabetes mellitus or those with renal impairment (Glomerular Filtration Rate < 60 mL/min/1.73 m^2). The co-administration of Lithium is generally not recommended because Indapamide decreases its urinary excretion, resulting in a documented increase in plasma Lithium concentration and a high risk of toxicity.


Pharmacodynamic and Electrolyte Interactions

Official labeling documents a heightened risk of ventricular arrhythmias and Torsades de pointes when Indapamide SR is combined with other Torsades de pointes-inducing medicines, due to the potential for hypokalaemia. This electrolyte-dependent toxicity risk is also relevant when co-administered with Digitalis preparations.

Interactions involving additive hypotensive effects are documented with ACE Inhibitors (risk of sudden hypotension) and Baclofen. Conversely, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may cause a reduction in the anti-hypertensive effect. For substances like Calcium salts, a decreased urinary elimination is documented, posing a risk of hypercalcaemia. The combination with Alcohol (Ethanol) may also lead to additive hypotensive effects.

Mechanism of Action

Dual Mechanism: Renal and Vascular Action

The action of Indapamide is defined by a dual mechanistic approach, engaging both the kidney's fluid regulation system and the functional dynamics of the peripheral blood vessels. This combined strategy produces the physiological consequences of reduced systemic pressure by influencing two key physiological drivers: fluid volume and vascular resistance.

Molecular Blockade of Salt Reabsorption

The primary molecular mechanism involves the competitive inhibition of the Na^+/ Cl^- Cotransporter ( NCC), which is located in the distal convoluted tubule of the nephron. By blocking this specific ion gate, Indapamide prevents the reabsorption of sodium and chloride ions back into the circulation. This initiates a mechanistic cascade where the increased salt in the tubular fluid draws water out by osmosis, leading to natriuresis and a net loss of circulatory fluid volume.

Direct Modulation of Peripheral Vascular Tone

Independent of its effect on fluid volume, the drug acts directly on the muscle cells of the arteries (vascular smooth muscle cells). This involves modulating ion handling, particularly reducing the availability or sensitivity of intracellular calcium ( Ca^2+) required for muscle contraction. This action results in the relaxation and widening of the arterioles (vasodilation), leading to a reduction in peripheral vascular resistance ( PVR). This contributes to the physiological consequence of reduced peripheral vascular resistance within the circulatory pathways.

Dosage and Administration Information

How to Use Indapen SR

The usage of Indapen SR is defined by a standardized set of instructions focusing exclusively on its proper administration and dosing patterns.

Administration Guidelines

Instruction Detail
Route of Administration The medication is approved for oral use only.
Dosing Schedule The standard regimen for essential hypertension is one 1.5 mg sustained-release tablet taken once per day. This dose is considered the maximum recommended for achieving the desired antihypertensive effect.
Intake Timing Administration is once daily, and the tablet should be taken preferably in the morning. It may be taken irrespective of meals (with or without food).
Preparation Requirements The sustained-release tablet must be swallowed whole with water. The tablet must not be crushed, broken, or chewed to preserve the controlled-release mechanism.
Course Duration The medication is intended for long-term use, consistent with the management of chronic conditions. Full therapeutic benefits may require several months to fully manifest.
Missed Dose Protocol If a dose is missed, patients should not take a double dose to compensate. The next tablet should be taken at the usual scheduled time.

Population-Specific Considerations

Standard clinical considerations include high-level factors for specific patient groups:

  • Older Adults: Treatment may be appropriate provided that renal function is normal or minimally impaired.
  • Renal/Hepatic Impairment: Caution is necessary, and the drug is primarily effective when renal function is not severely compromised.
  • Pediatric Use: The safety and efficacy of Indapamide SR have not been established for use in children and adolescents.

This protocol ensures the medication's controlled-release mechanism functions correctly and guides its use as part of a long-term management strategy, consistent with standard clinical guidance.

Recent Clinical Evidence

Research Evidence for Use in Essential Hypertension

Research has extensively explored the use of Indapen SR (Indapamide Sustained Release) in studies of persistently elevated systemic pressure (essential hypertension). The evidence base primarily consists of large-scale, randomized controlled trials (RCTs), where study participants are assigned randomly to receive the medicine, a placebo (dummy pill), or a different active medication. The use of Indapen SR was evaluated in trials involving adults of various ages, including older adults, with hypertension. Research examined outcomes related to systemic pressure measurements taken both in a clinic and throughout a full day using ambulatory monitoring.

Research Evidence for Use in Fluid Retention (Edema)

Indapen SR was studied in research examining the symptom of fluid retention (edema), particularly when associated with certain chronic heart conditions. Research explored temporary physiological imbalance by conducting dose-ranging clinical trials and regulatory efficacy studies. The research record indicates that data are often generalized from the Indapamide drug class as a whole, rather than the sustained-release (SR) formulation in dedicated edema trials.

Long-Term Studies and Maintenance of Effects

The research landscape includes studies that examined the outcomes related to extended use of Indapamide SR. For essential hypertension, studies monitored participants for periods ranging from three to five years to track data show patterns related to major cardiovascular events. Despite the existence of these long-term studies, long-term effects are not fully established for all possible patient groups or conditions. For example, while evidence suggests patterns in cardiovascular event rates for general hypertensive adults, long-term effects are not fully established regarding the durability of these patterns in every possible complex patient profile.

Evidence in Specific Patient Populations

Research examined the use of Indapen SR in various patient groups, including older adults and those with comorbidities like diabetes or mild-to-moderate kidney impairment. Data remain insufficient for certain groups, such as pediatric populations or patients with severe kidney impairment.

Key Studies & References

  1. Hypertension in adults: diagnosis and management (NICE Guideline 136, relevant treatment recommendations)

Frequently Asked Questions (FAQ)

Common questions about Indapen SR (FAQ)


Q: What is the main difference between Indapen SR and standard Indapamide?

The 'SR' (Sustained Release) formulation is designed to provide a prolonged, slow release of the medicine into the bloodstream. According to regulatory documents, this formulation aims for a smoother concentration profile of the drug over 24 hours, which supports its once-daily administration.


Q: Why is Indapen SR called 'SR' and what does 'prolonged-release' mean for patients?

The 'SR' designation stands for Sustained Release or prolonged-release. This means the tablet is designed to release the active ingredient slowly and steadily over a full day. This formulation enables a convenient, once-daily dosing regimen.


Q: Is Indapen SR a water pill, and how does it lower blood pressure?

Indapamide is referred to as a thiazide-like diuretic, which is often called a fluid tablet or 'water pill' by patients. Official information states it lowers blood pressure by increasing the excretion of sodium and water from the kidneys, and by directly relaxing the blood vessel walls.


Q: What are the most common side effects a new user might expect from Indapen SR?

The most frequently reported common side effects, as noted in official product information, include headache, dizziness, fatigue or weakness, and muscle cramps or spasms. Additionally, an increased urge to urinate is commonly noted, especially when starting treatment.


Q: Does Indapen SR cause low potassium (hypokalemia), and is this common?

Yes, official documents indicate that Indapamide is known to cause changes to the body’s salt balance, including low potassium levels (hypokalaemia). Regulatory warnings indicate that blood tests may be necessary to monitor the body's mineral balance during treatment.


Q: How quickly does Indapen SR start working to reduce blood pressure?

Indapamide typically begins to exert its effects within a few hours of taking it. However, a noticeable effect on blood pressure may take a couple of weeks to be seen, with the maximum blood pressure-lowering effect generally developing after three to four months of regular use.


Q: What are the risks of using Indapen SR for high blood pressure long-term?

The medication is intended for long-term use in managing chronic conditions. Official prescribing information indicates that regular blood and urine tests may be required to monitor the balance of salts (electrolytes) and check kidney function.


Q: Can Indapen SR affect my blood sugar levels or is it safe for people with diabetes?

Official documents state that Indapamide may potentially increase blood sugar (glucose) levels. For individuals with diabetes, the condition requires special consideration and regular biological monitoring as outlined in prescribing guidelines.


Q: Are there any specific lifestyle changes recommended while taking Indapen SR?

Patients are generally advised to follow a balanced diet and to avoid drinking large amounts of alcohol regularly. The medicine is compatible with making other beneficial lifestyle changes like increasing activity and managing stress.


Q: Does Indapen SR interact with common painkillers like ibuprofen or naproxen?

Yes, regulatory information indicates that Indapamide can interact with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which include common painkillers like ibuprofen. This combination may increase the risk of issues with kidney function, and regulatory documents suggest that caution may be warranted when these medications are co-administered.


Q: Is it necessary to have blood tests done regularly while on Indapen SR?

Official prescribing information indicates that regular blood and urine tests may be required for long-term treatment. This monitoring helps ensure that the salts (electrolytes) in the blood are balanced and that the kidneys are functioning well.


Q: What are the signs of low sodium (hyponatremia) that I should look out for?

Low sodium (hyponatremia) is a potential side effect. Official documents note that symptoms can include headache, dizziness, feeling weak or tired, confusion, and a reduced need to urinate.


Q: Can Indapen SR cause me to feel dizzy or lightheaded, especially when standing up?

Yes, dizziness or faintness, particularly when getting up suddenly from a sitting or lying position (orthostatic hypotension), is a reported side effect. This is especially important to note when first starting the treatment.


Q: Is it true that Indapen SR can increase my risk of developing gout?

Official prescribing information notes that Indapamide can cause hyperuricaemia (high uric acid), and gout has been reported rarely. Official documents note that individuals with a history of gout are a population that requires special consideration in prescribing.


Q: What is the connection between Indapen SR and an increased sensitivity to sunlight?

Official warnings note that Indapamide can cause increased sensitivity of the skin to sunlight (photosensitivity reactions). Protective measures against sun exposure may be appropriate during therapy.


Q: Does Indapen SR affect kidney function over time?

Indapamide is most effective when kidney function is normal or minimally impaired. Official guidelines state that kidney function should be monitored during long-term treatment. The medicine is contraindicated (should not be used) in severe renal failure.


Q: Is Indapen SR safe to use during pregnancy or while breastfeeding?

Indapamide SR is not recommended during pregnancy or while breastfeeding. Regulatory documents note that clinical experience in pregnancy is limited, and the medicine may pass into human breast milk.


Q: Can taking Indapen SR cause muscle cramps or spasms?

Yes, muscle cramps or spasms are listed as common side effects in official documentation. These symptoms can sometimes be related to the changes in electrolyte levels, specifically low potassium.


Q: Does Indapen SR have any known effects on sexual health or libido?

Official documents mention that decreased interest in sexual intercourse and inability to have or keep an erection have been reported as less common or infrequent side effects of the drug.


Q: Is Indapen SR the same as other diuretics like hydrochlorothiazide?

Indapamide is referred to as a thiazide-like diuretic. While it functions similarly to thiazide diuretics (like hydrochlorothiazide) by affecting salt handling in the kidney, official information notes that it is structurally different from them.


Q: Can I take Indapen SR if I have a known allergy to sulfa-based medicines?

Official prescribing information advises against taking Indapamide if an individual has a known allergy to sulfonamide (sulfa) type medications or thiazide diuretics. This is because Indapamide retains a sulfonamide component.


Q: What should I do if I notice a skin rash after starting Indapen SR?

If a rash develops, especially a severe rash with blistering or peeling (signs of serious skin reactions), official prescribing information indicates that such symptoms may necessitate discontinuing the medication and seeking immediate medical assessment.


Q: Do studies show that Indapen SR helps prevent heart attack or stroke?

Clinical trials examining Indapamide, often used alongside other medicines, have shown a reduction in cardiovascular mortality, total mortality, and the development of stroke compared to placebo or other treatments in specific patient groups.


Q: Can Indapen SR affect the results of other medical tests?

Yes, official documentation notes that Indapamide can affect the results of certain medical tests, including blood or urine sugar tests. It is also noted to contain an active ingredient that may give a positive reaction in doping tests.


Q: What are the non-blood pressure uses for Indapen SR, if any?

In addition to its main use for high blood pressure, Indapamide is officially indicated for the treatment of edema (fluid retention), a condition characterized by swelling caused by excess fluid in the body.


Q: Is Indapen SR a common first-line treatment for high blood pressure?

Official clinical reviews describe Indapamide as an effective antihypertensive agent. It is often used as a first-line drug or is included in combination therapy with other blood pressure medicines to manage high blood pressure.


Q: Is it safe to drive or operate machinery when starting Indapen SR treatment?

Due to the possibility of dizziness and lightheadedness, official guidance cautions against operating vehicles or heavy machinery until the individual knows how the medication affects them.


Q: Does Indapen SR interact with alcohol, or should I avoid drinking?

Drinking alcohol with Indapamide may increase the blood pressure-lowering effect, potentially causing dizziness or lightheadedness. Official guidance notes that the individual may wish to observe how the medicine affects them before consuming alcohol.


Q: What are the serious, but rare, side effects mentioned in official leaflets?

Serious side effects mentioned in official documents include severe allergic reactions (anaphylaxis), severe blistering skin reactions (like Stevens-Johnson Syndrome), liver damage, and inflammation of the pancreas (pancreatitis).


Q: Why is it important not to stop taking Indapen SR suddenly?

Official guidance notes that for high blood pressure, stopping Indapamide suddenly can cause blood pressure to rise rapidly. This increase can potentially heighten the risk of serious events such as a stroke or heart attack.


Q: Does Indapen SR contain lactose or any other known common allergens?

Official documents indicate the medicine may contain lactose. Individuals with rare hereditary problems such as galactose intolerance or lactase deficiency should be aware of this excipient, as usage is typically contraindicated.


Q: What should be done if vomiting or severe diarrhea occurs while taking Indapen SR?

Severe diarrhea or vomiting can lead to dehydration and low electrolyte levels. Regulatory information indicates that such persistent fluid loss may require prompt communication with a healthcare professional.


Q: Are there any specific dietary restrictions related to sodium or salt intake?

Because the medicine can cause low levels of salt in the body, very strict low-salt (low-sodium) diets are not generally recommended. Patients are typically advised to follow a balanced diet and keep salt intake moderate.


Q: Can Indapen SR worsen an existing condition like Lupus?

Official prescribing information notes that Indapamide may activate or worsen the inflammatory condition known as Systemic Lupus Erythematosus (SLE). Official documents note that individuals with this condition are a population requiring special consideration.

--TEMPORARY BREAK--

Q: Is it common to feel tired or weak when first starting Indapen SR?

Yes, fatigue, weakness, or loss of energy are listed as common side effects in official documentation. These effects may sometimes be linked to changes in the body's salt balance, such as low potassium.


Q: What does official data say about the risk of liver problems with Indapen SR?

Official documents state that liver damage (hepatotoxicity) is a possible side effect. The drug is contraindicated (should not be used) in severe hepatic impairment due to the risk of hepatic encephalopathy (a brain disorder caused by liver failure).


Q: Does Indapen SR interact with natural supplements like potassium or magnesium?

Since Indapamide affects salt balance and can lower potassium and magnesium levels, taking potassium supplements can change the levels in the blood. Regulatory information notes that co-administration should occur within the framework of professional medical guidance.


Q: Why is Indapen SR sometimes prescribed along with other blood pressure medicines?

Studies and official summaries show that the addition of low-dose Indapamide to other antihypertensive drugs has been shown to provide additional anti-hypertensive efficacy. This combination approach is common for better blood pressure control.


Q: How does Indapen SR affect the balance of salts and electrolytes in the body?

Indapamide may cause changes to the body's electrolyte levels (salts). Possible changes noted in official documents include low potassium (hypokalaemia) and low sodium (hyponatraemia). This is why professional monitoring may be required.


Q: Can Indapen SR cause a change in vision or eye pain?

Official documents mention the possibility of blurred vision, difficulty in reading, eye pain, and a change in near or distance vision. Rarely, it may also increase pressure inside the eye (glaucoma).


Q: Is the low-dose formulation of Indapen SR considered safer in terms of side effects?

Clinical studies have indicated that the risk of certain side effects, such as a reduction in serum potassium concentration, may be lower when using a minimal effective dose compared to a higher dose.


Q: Are there any warnings about Indapen SR and surgery or anesthesia?

Official clinical guidance notes that medications that lower blood pressure, including Indapamide, are sometimes recommended to be temporarily withheld before certain procedures involving other blood pressure-lowering agents.


Q: Is it true that taking Indapen SR can make me feel thirsty?

Yes, increased thirst (polydipsia) is listed as a potential symptom in official documentation. This can be related to the increased fluid loss caused by the medication's diuretic action.

How should Indapen SR be stored and disposed of?

How to Store and Dispose of Indapen SR

Indapen SR must be stored and disposed of strictly according to regulatory labeling to maintain product stability and ensure public safety.


Storage Requirements

Condition Regulatory Rule
Temperature Store below 30 C or at controlled room temperature (20 C to 25 C).
Protection Protect from light, moisture, and excess heat. Keep from freezing.
Container Store in the original container or blister pack and keep it tightly closed.
Child Safety Mandatory to keep the medicine out of the sight and reach of children.
Stability Do not use the medicine after the expiry date printed on the packaging.

Disposal Instructions

Unused or expired Indapen SR must not be disposed of in household waste or flushed down the toilet or drain. Official instructions require asking a healthcare professional or pharmacist how to discard the product. Disposal must follow local regulations for pharmaceutical waste, ensuring safe return to a designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Indapen SR found in:

A-Z Index: